✨ Your Portfolio is fetched and updated from zerodha.
Mid Pharmaceuticals

Ajanta Pharma Ltd.

AJANTPHARM

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹33,663 Cr.
P/E
36.20

Ajanta Pharma Ltd.

  • Ajanta Pharma
  • Gland Pharma
  • Ipca Laboratories
  • TJI Pharma
FAQs on Ajanta Pharma Ltd. Shareprice

Ajanta Pharma has given lower returns compared to its competitors.
Ajanta Pharma has grown at ~15.73% over the last 4yrs while peers have grown at a median rate of 17.91%

Yes, Ajanta Pharma is expensive.
Latest PE of Ajanta Pharma is 36.96, while 3 year average PE is 30.98.
Also latest EV/EBITDA of Ajanta Pharma is 26.7 while 3yr average is 22.61.

View FAQ's On Business
Growth Table
  • Ajanta Pharma Ltd.
  • Gland Pharma
  • Ipca Laboratories
Balance Sheet
  • Ajanta Pharma Ltd.
  • Gland Pharma
  • Ipca Laboratories
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Ajanta Pharma Ltd.
  • Gland Pharma
  • Ipca Laboratories
Cash Flow
  • Ajanta Pharma Ltd.
  • Gland Pharma
  • Ipca Laboratories
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Ajanta Pharma Ltd.
  • Gland Pharma
  • Ipca Laboratories
Quarterly Results
  • Ajanta Pharma Ltd.
  • Gland Pharma
  • Ipca Laboratories
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Ajanta Pharma Ltd. Financials

Balance sheet of Ajanta Pharma is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Ajanta Pharma is decreasing.
Latest net debt of Ajanta Pharma is -₹349.89 Crs as of Mar-25.
This is less than Mar-24 when it was -₹260.04 Crs.

Yes, profit is increasing.
The profit of Ajanta Pharma is ₹930 Crs for TTM, ₹920 Crs for Mar 2025 and ₹816 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Ajanta Pharma latest dividend payout ratio is 38.0% and 3yr average dividend payout ratio is 43.89%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech